Introduction: Worldwide, OSA is reported to affect nearly 1 billion adults aged 30-69 years,
making it a common condition with increased morbidity and mortality. The rate of several …

Introduction: OSA is a common disorder in adults and leads to increased morbidity and
mortality. However, data from large, randomized controlled clinical trials of PAP-treatment for …

Rationale: Data from recent large, randomized controlled clinical trials of PAP therapy
indicate that there are challenges to realising mortality benefits, particularly in patients with …

Background More information is needed about the effect on mortality of continuous positive
airway pressure (CPAP) in patients with obstructive sleep apnea (OSA), especially in …

Background Obstructive sleep apnoea (OSA) is a common condition that is associated with
several important comorbidities and increased mortality. Positive airway pressure (PAP) is …

Background There are limited data on long-term mortality in sleep apnoea (SA) patients with
and without positive airway pressure (PAP) therapy. This retrospective cohort study …

Study objectives To determine the short-term and long-term impacts of continuous positive
airway pressure (CPAP) therapy on health-related quality of life (HRQL) in patients with …

Objective Excessive daytime sleepiness (EDS) persists in some patients with obstructive
sleep apnea (OSA) despite continuous positive airway pressure (CPAP) treatment. This …

Introduction: Epidemiological studies suggest that obstructive sleep apnea (OSA) is
associated with increased mortality. Positive airway pressure (PAP) therapy is the treatment …

Objectives Adherence to continuous positive airway pressure (CPAP) in patients with
obstructive sleep apnea (OSA) is crucial. Our aim was to identify protective and risk factors …